{"SPADE_UN_18632": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18632", "Peptide Name": "gcDefb1 (grass carp beta-defensin 1; 3S=S; UCSS1a; natural AMPs; fish, animals; BBMm)", "Source": "brain and liver; grass carp,Ctenopharyngodon idella", "Family": "Not found", "Gene": "Not found", "Sequence": "MKPQSILVLLVLAVLALHCKENEAASFPWTCASLSGVCRQGVCLPSELYFGSLGCGKGFLCCVSHFG", "Sequence Length": 67, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram-", "Anti-inflammatory"], "Hemolytic Activity": "In vitro toxicity: murine RBC: only 1.26% hemo.lysis up to 600 ug/ml.", "Cytotoxicity": "Also not toxic to RAW 264.7 cells till 500 ug/ml (MTT assay).", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "C318H503N80O86S8", "Mass": 7091.39, "PI": 7.57, "Hydrophobicity": 0.77, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Yang K, Hou B, Ren F, Zhou H, Zhao T.2018", "Reference": "Biosci Biotechnol Biochem. 2018 Oct 8:1-8. doi: 10.1080/09168451.2018.1519386.PubMed", "Title": "Characterization of grass carp (Ctenopharyngodon idella) beta-defensin 1: implications for its role in inflammation control."}], "Frequent Amino Acids": "LCG", "Absent Amino Acids": "DOU", "Basic Residues": 6, "Acidic Residues": 3, "Hydrophobic Residues": 33, "Polar Residues": 36, "Positive Residues": 6, "Negative Residues": 3, "Net Charge": 3, "Mechanism of action": "It also inhibits biofilmB formation of E. coli (Dong et al., 2022).", "Target Organism": "While thioredoxin was not antimicrobial, fusion Trx-Defb1 inhibited the growth of A. hydrophila ATCC 7966 (MIC 36 uM). The bacterial growth in Trx-Defb1-treated group was sharply inhibited by more than 90% compared with PB and Trx groups, indicative of a lack of activity of Trx portion. It inhibits LPS-induced TNF-alpha and NO (anti-inflammatory). Another study using recombinant peptide found active against Gram+ L. monocytogenes ATCC 221,633 (MIC 60 ug/ml), S. aureus ATCC 25,923 (MIC 80 ug/ml), Gram- E. coli ATCC 25,922 (MIC 30 ug/ml), and S. typhimurium ATCC 14,028 (MIC 50 ug/ml).", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05618", "Similarity": 0.813953488372093, "Sequence": "VSFPWSCAALSGVCRQGACLPSELYFGPLGCGKGSLCCVSYFL"}, {"SPADE_ID": "SPADE_N_02091", "Similarity": 0.8095238095238095, "Sequence": "ASFPWSCPSLSGVCRKVCLPTELFFGPLGCGKGFLCGVSHFL"}, {"SPADE_ID": "SPADE_N_15748", "Similarity": 0.725, "Sequence": "FPWSCPTLSGVCRKVCLPTEMFFGPLGCGKEFQCCVSHFF"}]}}}